Swine Hemorrhage Model
Swine Hemorrhage Model - Related Videos
08:27
A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
0 Views •
Cited by 1 •
2024
This study presents a hybrid quantitative model for axillary junctional hemorrhage in swine, enhancing pre-hospital hemostatic intervention evaluation.
09:09
Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
0 Views •
Cited by 1 •
2023
This article aims to provide researchers with a detailed and accessible guide to set up an infant porcine model of hemorrhagic shock.
07:57
Integrated Compensatory Responses in a Human Model of Hemorrhage
0 Views •
Cited by 11 •
2016
The purpose of this protocol is to demonstrate the techniques for measuring compensatory responses to reduced central blood volume using lower body negative pressure as a noninvasive experimental model of human hemorrhage which can be used to quantify the total integration of compensatory mechanisms to blood volume deficit in humans.
02:29
Modeling Drug-Induced Hemorrhage in Zebrafish Larva
0 Views •
2025
In this video, fertilized zebrafish embryos are dechorionated under a stereo microscope and then exposed to a cholesterol synthesis inhibitor, leading to the development of blood vessel ruptures and brain hemorrhages in the larvae. Hemorrhagic larvae, identifiable by distinct red spots, are subsequently separated under a microscope for further analysis.
16:31
Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
0 Views •
Cited by 24 •
2011
The Hemorrhagic Shock model has been a reliable and reproducible resource facilitating the identification and understanding of signaling cascades associated with inflammation and end-organ damage after trauma. This article provides a step-by-step description of surgical and mechanical aspects associated with the Hemorrhagic Shock experimental procedure in mice.
FAQs
Progressive blood removal first reduces circulating volume and oxygen delivery, prompting compensatory tachycardia and vasoconstriction. As hemorrhage continues, these responses become insufficient, and hypotension develops alongside tissue hypoperfusion. This sequence allows investigators to examine changing cardiovascular compensation and the transition from an initially compensated state to more severe shock-related dysfunction.
Reduced circulating volume limits oxygen delivery to tissues, linking blood loss to metabolic and organ consequences rather than treating hemorrhage as only a change in blood pressure. Tracking this relationship helps researchers interpret how cardiovascular responses, declining perfusion, and subsequent interventions influence tissue oxygenation and organ function during severe hemorrhage.
Tachycardia and vasoconstriction are compensatory cardiovascular responses to falling circulating volume and oxygen delivery. Their appearance indicates that the organism is attempting to preserve circulation before hypotension and tissue hypoperfusion become prominent. Measuring these responses helps distinguish compensation from later decompensation and provides physiological context for evaluating resuscitation effects.
Hemodynamic and metabolic changes are central measurements during the experiment. Hemodynamic observations help characterize cardiovascular compensation, hypotension, and perfusion, while metabolic measurements provide complementary information about the consequences of inadequate oxygen delivery. Together, these data show how shock progresses and how treatment changes physiological status and organ-related outcomes.
After hemorrhage produces defined physiological changes, researchers can assess how fluid or blood-product resuscitation alters hemodynamic and metabolic responses. The model supports comparison of treatment effects on circulation, tissue perfusion, and organ function within a controlled experimental setting. These observations help identify whether an intervention improves the consequences of severe blood loss.
The platform permits controlled study of injury, shock, and treatment effects on organ function before clinical evaluation. Researchers can test resuscitation approaches, devices, and therapeutics while monitoring the associated hemodynamic and metabolic changes. Findings can therefore clarify treatment responses and provide preclinical evidence relevant to managing hemorrhagic shock in medicine.